25 May 2013
Keywords: hemophiliacs, aids, factor, viii, clinical, evidence, continuing
Article | 14 June 1993
Clinical evidence is continuing to show that monoclonal
antibody-purified Factor VIII therapy in hemophilia A reduces the
progression of HIV ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 March 1993
25 January 1993
24 May 2013
© 2013 thepharmaletter.com